药品开发市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00024322
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

药物开发市场预计在 2023 年至 2031 年期间的复合年增长率为 9.2%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告细分为药物类型(小分子药物和生物药物);技术(高通量筛选、药物基因组学、组合化学、纳米技术和其他技术);最终用途(制药公司、合同研究组织 (CRO) 和其他最终用户),

全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。

报告目的

Insight Partners 的《药物开发市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

药物开发市场细分

 

药物类型

  • 小分子药物
  • 生物药物

技术

  • 高通量筛选
  • 药物基因组学
  • 组合化学
  • 纳米技术
  • 其他技术

最终用途

  • 制药公司
  • 合同研究组织
  • 其他最终用户

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

药物开发市场:战略洞察

Drug Development Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

药物开发市场的增长动力

  • 慢性病发病率高:癌症、糖尿病、心血管疾病等全球慢性病是药物开发行业的重要驱动力。对治疗甚至治愈这些疾病的新疗法和治疗方法的需求维持了对研发活动的投入,并推动了制药行业的增长。
  • 生物技术和基因组学:生物技术、基因组学和个性化医疗正在加速药物开发。CRISPR 基因编辑、RNA 疗法和生物制剂等技术都改变了药物开发的格局。这为候选药物创造了新的机会,主要是在罕见和复杂疾病方面,从而推动了市场的增长。
  • 老龄人口增加:全球老龄人口正在增加对药品的需求,主要是用于治疗与年龄相关的疾病(如阿尔茨海默氏症、关节炎和骨质疏松症)的药品。老年人口通常需要专门的治疗;这是药物开发市场的主要驱动力,因为老年人对定制治疗的需求日益增长

药物开发市场未来趋势

  • 精准医疗的兴起:其中,精准医疗的发展速度很快,即根据个人的基因特征调整药物治疗。通过利用基因信息设计更加个性化的疗法,制药公司可以提高治疗效果、最大限度地减少副作用并帮助治愈未满足的医疗需求。这一趋势正在改变药物开发的进程,尤其是针对肿瘤学和罕见疾病。
  • 制药公司和科技公司之间的合作更加紧密:人工智能和大数据分析越来越多地被整合到药物开发中。制药公司和科技公司之间更好的合作使得新药的发现和交付速度更快,临床试验设计得到改善,药物开发流程也更加简化。预测药物疗效:人工智能降低了成本并加快了上市时间。
  • 新疗法的出现:随着监管环境(例如通过孤儿药地位)和患者倡导的不断增加,开发更多针对罕见病和孤儿病的治疗方法的趋势正在增加。随着制药公司努力满足规模较小、服务不足的患者群体中未满足的医疗需求,这一趋势促进了药物开发的创新

药物开发市场机会

  • 进军新兴市场:新兴市场是药物开发的绝佳机会。中国、印度和巴西等市场医疗保健意识的提高、医疗保健基础设施的改善以及治疗机会的增加极大地推动了对新药的需求。通过向这些地区扩张,公司可以利用大量尚未开发的患者群体,尤其是慢性病管理。
  • 采用数字健康工具:数字健康工具(包括可穿戴和移动健康应用程序)为药物开发商提供了更密切地跟踪患者结果的机会。由于这些技术能够报告实时数据,因此它们可以加强临床试验监测、患者依从性、疗效跟踪、有针对性的治疗,并优化药物开发阶段的流程。
  • 生物制剂和生物仿制药:生物制剂迅速受到患者的欢迎,因为它们可以精确地针对复杂的疾病。但现在,随着许多生物药物的专利到期,开发生物仿制药的机会也随之增加——生物仿制药是价格实惠的生物制剂的品牌替代品。对于创新者和仿制药制造商来说,开发低成本的生物药物替代品的市场机会巨大且不断增长。

 

药物开发市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响药物开发市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的药物开发市场细分和地理位置。

Drug Development Market
  • 获取药物开发市场的区域特定数据

药物开发市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)9.2%
史料2021-2022
预测期2024-2031
涵盖的领域按药物类型
  • 小分子药物
  • 生物药物
按技术分类
  • 高通量筛选
  • 药物基因组学
  • 组合化学
  • 纳米技术
  • 其他技术
按最终用途
  • 制药公司
  • 合同研究组织
  • 其他最终用户
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 基因生物制剂
  • 雅培实验室公司
  • 安捷伦科技公司
  • 阿斯利康公司
  • AVIVA 生物科学
  • 拜耳公司
  • Biotica 制药公司
  • 百时美施贵宝公司
  • 合作药物研发公司

 

药物开发市场参与者密度:了解其对业务动态的影响

药物开发市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明相对于给定市场空间的规模或总市场价值,有多少竞争对手(市场参与者)存在于该市场空间中。

在药物开发市场运营的主要公司有:

  1. 基因生物制剂
  2. 雅培实验室公司
  3. 安捷伦科技公司
  4. 阿斯利康公司
  5. AVIVA 生物科学

免责声明上面列出的公司没有按照任何特定顺序排列。


Drug Development Market

 

  • 了解药物开发市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了药物开发市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,药物开发市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are some of the major players operating in the market?

Genome Biologics Abbott Laboratories Inc. Agilent Technologies Inc. AstraZeneca PLC AVIVA Biosciences Bayer AG Biotica Pharma. Bristol-Myers Squibb Company Collaborative Drug Discovery Inc.

Which region accounts for highest revenue share of drug development market?

North America region accounts for highest revenue share of drug development market

What years does this drug development include?

The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)

Who are the prominent players in the drug development Market?

Genome Biologics Abbott Laboratories Inc. Agilent Technologies Inc. AstraZeneca PLC AVIVA Biosciences Bayer AG Biotica Pharma. Bristol-Myers Squibb Company Collaborative Drug Discovery Inc. Source: https://www.theinsightpartners.com/reports/drug-development-market

Which is the fastest growing region in drug development Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023: 2031)

At what CAGR the drug development Market projected to grow?

The market is expected to grow at a CAGR of 9.2%

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Genome Biologics
2. Abbott Laboratories Inc.
3. Agilent Technologies Inc.
4. AstraZeneca PLC
5. AVIVA Biosciences
6. Bayer AG
7. Biotica Pharma.
8. Bristol-Myers Squibb Company
9. Collaborative Drug Discovery Inc.
10. DeepBiome Therapeutics
11. Eli Lilly and Company
12. F. Hoffmann-La Roche Ltd
13. Gilead Sciences Inc.
14. GlaxoSmithKline PLC
15. Merck & Co. Inc.
16. Novartis
17. Pfizer Inc.
18. Shimadzu Corp.
19. Takeda Pharmaceuticals
20. Teva Pharmaceuticals

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.